Therefore, further studies about S100B and inflammatory markers in schizophrenia and other psychiatric disorders from large-scale populations and strictly control of confounding variables are necessary to elucidate the role of S100B and inflammatory markers in schizophrenia, and values of biomarker. This evidence concerns the gene S100B and schizophrenia.